Carisma Therapeutics, Inc. (CARM)
OTCMKTS · Delayed Price · Currency is USD
0.0360
-0.0000 (-0.14%)
At close: Mar 20, 2026
Carisma Therapeutics Market Cap
Carisma Therapeutics has a market cap or net worth of $1.5 million as of March 20, 2026. Its market cap has decreased by -90.88% in one year.
Market Cap
1.50M
Enterprise Value
-510.67K
Revenue
52.63M
Ranking
n/a
PE Ratio
0.19
Stock Price
$0.04
Market Cap Chart
Since March 8, 2023, Carisma Therapeutics's market cap has decreased from 147.73M to 1.50M, a decrease of -98.98%. That is a compound annual growth rate of -77.93%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 20, 2026 | 1.50M | -16.40% |
| Dec 31, 2025 | 1.80M | -89.71% |
| Dec 31, 2024 | 17.48M | -85.21% |
| Dec 29, 2023 | 118.25M | -19.96% |
| Mar 8, 2023 | 147.73M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| ZyVersa Therapeutics | 2.03M |
| Biomind Labs | 1.99M |
| LakeShore Biopharma | 1.82M |
| Agentix | 1.68M |
| Oncology Pharma | 1.55M |
| Exousia Pro | 1.55M |
| inTerra Resources | 1.49M |
| Enzolytics | 1.45M |